Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K, Date: 2012-03-27, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: BSPM/20120327/10-K/1/000.htm SEC Original: biostarpharna10k123111.htm
FORM 10-K (Mark One) x December 31, 2011 For the fiscal year ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China

---

---

Webplus: BSPM/20120327/10-K/2_EX-21/000.htm SEC Original: ex21.htm
List of subsidiary / variable interest entities of Biostar Pharmaceuticals, of December 31, 2011 Subsidiary Place oforporation Shaanxi Biostar BioTech Peoples Republic of China Variable interest entities Place oforporation Shaanxi Aoxing Pharmaceutical Peoples Republic of China Shaanxi Weinan Aoxing Pharmaceuticals, Peoples Republic of China

---

---

Webplus: BSPM/20120327/10-K/3_EX-23.1/000.htm SEC Original: ex23-1.htm
Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to yourorporation of our audit reportted March 27, 2012 relating to thensolidated financial statements of Biostar Pharmaceuticals, of and for each of the years ended December 31, 2011 and 2010 in the Annual Report on Form 10-K of

---

---

Webplus: BSPM/20120327/10-K/4_EX-23.2/000.htm SEC Original: ex23-2.htm
Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, (No. 333-161598) We herebynsent to theorporation by reference in the Registration Statement on Form S-8 Mazars CPA Limited Certified Public Accountants Hong Kong March 27, 2012 ex23-2.htm 4 EX-23.2

---

---

Webplus: BSPM/20120327/10-K/5_EX-31.1/000.htm SEC Original: ex31-1.htm
CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with

---

---

Webplus: BSPM/20120327/10-K/6_EX-31.2/000.htm SEC Original: ex31-2.htm
CERTIFICATION I, Zack Zibing Pan, certify that: 1. I have reviewed this annual 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

---

---

Webplus: BSPM/20120327/10-K/7_EX-32.1/000.htm SEC Original: ex32-1.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 7 EX-32.1

---

---

Webplus: BSPM/20120327/10-K/8_EX-32.2/000.htm SEC Original: ex32-2.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 8 EX-32.2

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K, Date: 2012-03-27, XBRL Interactive FinancialsCIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046